US8354311073 - Common Stock
NYSE:SONX (2/3/2023, 7:08:44 PM)-0.04 (-1.54%)
|GICS Sector||Health Care|
|GICS Industry||Health Care Equipment & Supplies|
|Earnings (Last)||11-09 2022-11-09/amc||Earnings (Next)||N/A N/A|
|Ins Owners||5.34%||Inst Owners||N/A|
Find more stocks on New York Stock Exchange, Inc.
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 219 full-time employees. The company went IPO on 2021-10-29. The Company’s segments include Product and Software. The Product segment includes GentleWave System console and related accessories and instruments. GentleWave System is a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. GentleWave System offers a novel approach to root canal therapy, using advanced fluid dynamics, broad-spectrum acoustic energy and accelerated chemistry to deliver optimal cleaning and disinfection of the root canal system. Software segment includes selling traditional software licenses for practice management software to enable an integrated digital office for endodontists as well as Software-as-a-Service subscriptions. The company also offers ancillary single use products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid.
Suite 101, 26061 Merit Circle
Laguna Hills CALIFORNIA
CEO: Bjarne Bergheim
Sonendo (SONX) on Wednesday said its unit PIPStek had filed a patent infringement lawsuit against maker of dental lasers Biolase (BIOL). Read more on the lawsuit here.
Here you can normally see the latest stock twits on SONX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.